Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | PLAU | P00749 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4296416 | 0.86 | LMNA (0.56) | L3MBTL1MAPTSRD5A2RAB9ANPC1 | |
| SCHEMBL15197228 | 0.85 | GRM1 (0.60) | L3MBTL1MAPTSRD5A2RAB9ANPC1 | |
| SCHEMBL6284274 | 0.83 | CCNC (0.51) | CES2CES1L3MBTL1MAPTRAB9A | |
| SCHEMBL257535 | 0.82 | NPC1 (0.53) | L3MBTL1MAPTSRD5A2RAB9ANPC1 | |
| SCHEMBL6204532 | 0.82 | TAS1R3 (0.56) | L3MBTL1MAPTSRD5A2RAB9ANPC1 | |
| SCHEMBL15191689 | 0.82 | PIK3CA (0.51) | CES2CES1L3MBTL1MAPTRAB9A | |
| SCHEMBL1555065 | 0.82 | KMT2A (0.54) | CES2CES1L3MBTL1MAPTSRD5A2 | |
| SCHEMBL13400965 | 0.82 | MEN1 (0.45) | CES2CES1L3MBTL1MAPTRAB9A | |
| SCHEMBL7129800 | 0.80 | MAPT (0.80) | CES2CES1L3MBTL1MAPTSRD5A2 | |
| SCHEMBL14982170 | 0.80 | KMT2A (0.67) | CES2CES1L3MBTL1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9805707-B2 | Sound absorbing and insulating material and method for manufacturing the same | HYUNDAI MOTOR COMPANY (KR) | 2017-10-31 | — | — | US | disclosed |
| US-20170032776-A1 | SOUND ABSORBING AND INSULATING MATERIAL AND METHOD FOR MANUFACTURING THE SAME | HYUNDAI MOTOR COMPANY (KR) | 2017-02-02 | — | — | US | disclosed |
| US-20160300560-A1 | SOUND ABSORBING AND INSULATING MATERIAL AND METHOD FOR MANUFACTURING THE SAME | HYUNDAI MOTOR COMPANY (KR) | 2016-10-13 | — | — | US | disclosed |
| US-8895552-B2 | Cyclic amide derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-8821617-B2 | Polyimide-co-polybenzoxazole copolymer, preparation method thereof, and gas separation membrane comprising the same | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, HANYANG UNIVERSITY (KR) | 2014-09-02 | — | — | US | disclosed |
| US-8642722-B2 | Preparation method of polybenzimidazole | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2014-02-04 | — | — | US | disclosed |
| US-20130217692-A1 | CYCLIC AMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8487064-B2 | Polymer compounds and a preparation method thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, HANYANG UNIVERSITY (KR) | 2013-07-16 | — | — | US | disclosed |
| US-8232367-B2 | Polymer compounds and a preparation method thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, HANYANG UNIVERSITY (KR) | 2012-07-31 | — | — | US | disclosed |
| US-8163071-B2 | Hollow fiber, dope composition for forming hollow fiber, and method of preparing hollow fiber using the same | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2012-04-24 | — | — | US | disclosed |
| US-20120042777-A1 | GAS SEPARATION USING MEMBRANES COMPRISING POLYBENZOXAZOLES PREPARED BY THERMAL REARRANGEMENT | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2012-02-23 | — | — | US | disclosed |
| US-20110230605-A1 | Polymer compounds and a preparation method thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, HANYANG UNIVERSITY (KR) | 2011-09-22 | — | — | US | disclosed |
| US-20110065823-A1 | POLYIMIDE-CO-POLYBENZOXAZOLE COPOLYMER, PREPARATION METHOD THEREOF, AND GAS SEPARATION MEMBRANE COMPRISING THE SAME | Industry-University Cooperation Foundation, Hanyan g University (KR) | 2011-03-17 | — | — | US | disclosed |
| US-20110009506-A1 | PREPARATION METHOD OF POLYBENZOXAZOLES BY THERMAL REARRANGEMENT, POLYBENZOXAZOLES PREPARED THEREBY, AND GAS SEPARATION MEMBRANE COMPRISING THE SAME | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2011-01-13 | — | — | US | disclosed |
| EP-0659737-B1 | Catecholamine surrogates useful as beta 3 agonists | BRISTOL MYERS SQUIBB CO (US) | 2003-03-26 | — | — | EP | disclosed |
| US-5776983-A | ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0659737-A2 | Catecholamine surrogates useful as B3 agonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217692-A1 | CYCLIC AMIDE DERIVATIVE | HDAC10, H1-10, H1-0 | CES2 420/4885CES1 811/4885L3MBTL1 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.